Compare POET & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POET | AGL |
|---|---|---|
| Founded | 1972 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2008 | 2021 |
| Metric | POET | AGL |
|---|---|---|
| Price | $10.16 | $109.98 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $55.68 |
| AVG Volume (30 Days) | ★ 29.2M | 287.7K |
| Earning Date | 08-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.94 |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | $848.96 | N/A |
| Revenue Next Year | $700.00 | $4.23 |
| P/E Ratio | ★ N/A | $39.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.87 | $0.30 |
| 52 Week High | $20.65 | $125.71 |
| Indicator | POET | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 58.31 |
| Support Level | $10.11 | $0.53 |
| Resistance Level | $15.51 | N/A |
| Average True Range (ATR) | 1.26 | 11.18 |
| MACD | -0.34 | -1.82 |
| Stochastic Oscillator | 23.36 | 48.50 |
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.